Key facts
- This page summarizes Ted Murphy's Form 4 filing for Co-Diagnostics, Inc. (CODX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 09 Jan 2023, 15:30.
Ted Murphy - 08 Jan 2023 Form 4 Insider Report for Co-Diagnostics, Inc. (CODX)
- Reporting relationship
- Director
- Issuer ticker
- CODX
- Reported as of
- 08 Jan 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 09 Jan 2023, 15:30:33 UTC
- Prior SEC filing
- 23 Nov 2022
- Next SEC filing
- 19 Jan 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Edward L. Murphy
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Ted Murphy filed Form 4 for Co-Diagnostics, Inc. (CODX) on 09 Jan 2023.
Change
- Previous filing in this sequence was filed on 23 Nov 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CODX
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +12,500
- Change %
- +34%
- Price
- $0.000000
- Shares after
- 49,167
- Date
- 08 Jan 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CODX
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -12,500
- Change %
- -18%
- Price
- $0.000000
- Shares after
- 58,333
- Date
- 08 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 70,833
- Exercise price
- $0.000000
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Included in 37,500 restricted stock units awarded to the Reporting Person on January 8, 2021, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in three equal installments every twelve months commencing on January 8, 2021. Included in 70,000 restricted stock units awarded to the Reporting Person on July 11, 2022, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on November 23, 2022.